D
AVITA Medical, Inc. RCEL
$4.60 -$0.28-5.74% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -3.50% -27.28% -74.80% -70.25% -63.13%
Total Depreciation and Amortization 136.41% 106.29% 78.16% 57.22% 38.07%
Total Amortization of Deferred Charges -- -- -- -74.71% -49.56%
Total Other Non-Cash Items 200.39% 334.70% 453.95% 0.86% -39.82%
Change in Net Operating Assets 100.76% 119.06% 28.84% 37.60% -282.30%
Cash from Operations 33.00% 22.93% -28.75% -69.11% -119.30%
Capital Expenditure -33.07% -267.42% -564.08% -580.09% -507.27%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 1,079.23% 31,675.38% 1,457.36% -125.58% -113.05%
Cash from Investing 443.65% 1,664.00% 2,225.02% -140.20% -131.35%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 7.27% 56.37% 117.62% 71.48% 121.60%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -92.89% -92.07% -91.31% 2,176.97% 3,245.04%
Foreign Exchange rate Adjustments -- -- -- -103.45% -165.52%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 73.86% 81.25% -304.05% -219.14% -886.84%